MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12876-026-04839-w

Медицинская библиотека · BMC gastroenterology · 2026

Blood-based non-invasive tests show comparable accuracy in MetALD and MASLD for MRE-defined advanced fibrosis.

Roy Akash, Jajodia Surabhi, Chakraborty Shardhya, Keyal Shruti, Tewari Awanish, Sonthalia Nikhil, Roy Sourish, Khandelwal Rajat, Kulkarni Anand, Ghoshal Uday Chand, Reddy Rajender, Goenka Mahesh Kumar

СтатьяСравнительное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Non-invasive tests (NITs) triage individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) for advanced fibrosis (AF). However, evidence for performance in metabolic dysfunction and alcohol-associated liver disease (MetALD) remains limited. AIM: To determine how commonly used NITs perform in MetALD and MASLD using magnetic resonance elastography (MRE) as the reference.

METHODS

Adults (≥ 18 years) with MASLD /MetALD with cardiometabolic risk factors (CMRFs) and MRI proton density fat fraction-defined steatosis were included. Fibrosis-4 (FIB-4), AST platelet ratio index (APRIF), and NAFLD fibrosis score (NFS) were estimated. Contemporaneous MRE served as the comparator with a cut-off for AF of 3.53 kPa and sensitivity analysis at 3.6 kPa.

RESULTS

Among 1010 individuals [44 (35-54 years), 35.2% females], 842(83.3%) had MASLD and 168(16.6%) had MetALD. CMRF [diabetes,36.6% vs.30.9%, p = 0.15], hypertension (38.2% vs. 34.5% p = 0.36), dyslipidaemia (31.5% vs. 33.9%, p = 0.55), and burden of AF (15.4% vs. 18.4%, p = 0.33) were similar. APRI was suboptimal [AUC 0.63 (0.60–0.66)]. In MASLD, the AUC for FIB-4 and NFS were 0.77 (0.72–0.82) and 0.80 (0.76–0.85), respectively. For MetALD, the AUC of FIB-4 and NFS were 0.78 (0.68–0.87) and 0.81 (0.70–0.89), respectively. FIB-4 (AUC 0.770 vs. 0.782, p = 0.99) and NFS (AUC 0.804 vs. 0.80, p = 0.94) had similar performance. Sensitivity analysis at 3.6 kPa threshold yielded similar results.

CONCLUSION

In a liver clinic cohort, MASLD and MetALD showed similar CMRF and AF burden. FIB-4 and NFS, but not APRI, show clinically useful and similar performance for AF, supporting inexpensive standard NIT-based triage in MetALD.

Для цитирования: Roy Akash, Jajodia Surabhi, Chakraborty Shardhya, Keyal Shruti, Tewari Awanish, Sonthalia Nikhil, Roy Sourish, Khandelwal Rajat, Kulkarni Anand, Ghoshal Uday Chand, Reddy Rajender, Goenka Mahesh Kumar. Blood-based non-invasive tests show comparable accuracy in MetALD and MASLD for MRE-defined advanced fibrosis.. BMC gastroenterology. 2026. DOI: 10.1186/s12876-026-04839-w.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.